Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 6, 1996 - Issue 2
Submit an article Journal homepage
6
Views
0
CrossRef citations to date
0
Altmetric
Research

Patent Evaluation Oncologic, Endocrine & Metabolic: Novel tyrosine kinase inhibitors

Pages 211-212 | Published online: 29 Feb 2008
 
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Abstract

Two heterocyclic series of compounds, both bicyclic and tricyclic, are disclosed in two patent applications as novel EGFR inhibitors with claims including utilities in treating human diseases such as cancer, diabetes and pancreatitis.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.